Nature Medicine, Published online: 10 August 2026; doi:10.1038/s41591-026-04550-z
Rather than intervening when dysglycemia is established, prevention efforts should focus on prediabetes remission and restoration of normoglycemia. Here the authors call for a new agenda informed by mechanistic heterogeneity, a life-course risk architecture and scalable precision tools.
